The stock price

[anonymous]

52 week low. Down 31% YTD. About the same price as January 2020.

we have bungled our way through billions upon billions in Covid product sales, built no new trust with investors and have inspired no new confidence in our ability to do anything other than richly reward top executives.

in 2023, we are equivalent to a CD with downside risk

 

[anonymous]

52 week low. Down 31% YTD. About the same price as January 2020.

we have bungled our way through billions upon billions in Covid product sales, built no new trust with investors and have inspired no new confidence in our ability to do anything other than richly reward top executives.

in 2023, we are equivalent to a CD with downside risk

None of this is a surprise. Wall St has long known that we are merely a sales company that has a huge field force and an eye for companies to swallow up. It's been this way since McKinnell took over. I say that for awhile, it worked because we bought companies with drugs that blockbustered Pfizer into relevance. Where would we have been in 2007 if not for Lipitor, Celebrex and oncology pipeline? We had wrung Zoloft and Zithromax out (hello, price increases!), were at year 10 for Viagra and were staring at a precipitous patent cliff.

I am confident that our squandering of the absolute lottery ticket of a Covid vaccine will be discussed at B schools for quite some time.

 

[anonymous]

None of this is a surprise. Wall St has long known that we are merely a sales company that has a huge field force and an eye for companies to swallow up. It's been this way since McKinnell took over. I say that for awhile, it worked because we bought companies with drugs that blockbustered Pfizer into relevance. Where would we have been in 2007 if not for Lipitor, Celebrex and oncology pipeline? We had wrung Zoloft and Zithromax out (hello, price increases!), were at year 10 for Viagra and were staring at a precipitous patent cliff.

I am confident that our squandering of the absolute lottery ticket of a Covid vaccine will be discussed at B schools for quite some time.

Agreed. Perhaps law schools should also prepare some case studies for shareholder lawsuits on poor management, malfeasance and otherwise operating outside of shareholder interests. Insane rewards for a self congratulatory moon shot should be followed with expectations for increased market performance, not rapid declines back past the mean.

 

[anonymous]

Agreed. Perhaps law schools should also prepare some case studies for shareholder lawsuits on poor management, malfeasance and otherwise operating outside of shareholder interests. Insane rewards for a self congratulatory moon shot should be followed with expectations for increased market performance, not rapid declines back past the mean.

some things are more important than stock price, investor returns...we will continue to be the leading DEI, LGBT+, ESG investing company in the industry!

 

[anonymous]

Everyone is underwater on their stock or options but if you didn’t make 6 figures from stock during the pandemic thats on you

 

[anonymous]

Everyone is underwater on their stock or options but if you didn’t make 6 figures from stock during the pandemic thats on you

Yeah, I hope most people did. During the pandemic run up on covid vaccines sales, I pulled some off the table in the mid fifties. I didn’t hit the top like AB and the insiders, but I’m ok with what I pulled off my holdings.

what I am not ok with is how AB and the insiders have bungled this whole scenario. While they have become individually wealthy, they have completely lost the opportunity to redefine how PFE is perceived as a vaccine leader, an effective communicator that shapes narratives or as a trusted place for investors to get reasonable returns. We should do more than compete for CD investors, we could be a leader in healthcare stocks. Billions upon billions sold, opportunities squandered and drift back to below the pre pandemic mean. Just absolutely awful leadership. Maybe the next book can be called Rimshot.

 

[anonymous]

some things are more important than stock price, investor returns...we will continue to be the leading DEI, LGBT+, ESG investing company in the industry!

Do you get paid to post that same corny response to popular threads here? If so, please add the phrase "go woke, go broke" so that you can add 25% to your fee.

I look forward to you adding that response to many, many more threads in the future!

 

[anonymous]

Yeah, I hope most people did. During the pandemic run up on covid vaccines sales, I pulled some off the table in the mid fifties. I didn’t hit the top like AB and the insiders, but I’m ok with what I pulled off my holdings.

what I am not ok with is how AB and the insiders have bungled this whole scenario. While they have become individually wealthy, they have completely lost the opportunity to redefine how PFE is perceived as a vaccine leader, an effective communicator that shapes narratives or as a trusted place for investors to get reasonable returns. We should do more than compete for CD investors, we could be a leader in healthcare stocks. Billions upon billions sold, opportunities squandered and drift back to below the pre pandemic mean. Just absolutely awful leadership. Maybe the next book can be called Rimshot.

We have an RSV vaccine and others in development that look promising... the vaccine business is growing. We haven't done as many cool things as Moderna, but we down own the tech like BioNTech does.

2.0 multipliers for years, 1.5+ for years... We all got wealthy.

 

[anonymous]

As an investment, I like the analogy of PFE being like a CD but with downside risk.

we are also analogous to a fool who wins the lottery. Blow through the money in two years, have nothing to show for it. No plan, just a hope for another bonanza from somewhere.

 

[anonymous]

As an investment, I like the analogy of PFE being like a CD but with downside risk.

we are also analogous to a fool who wins the lottery. Blow through the money in two years, have nothing to show for it. No plan, just a hope for another bonanza from somewhere.

bought seagen and biohaven... not really blown when you look at how they can do what we cant which is have success with in-house products and proven MOAs

 

[anonymous]

bought seagen and biohaven... not really blown when you look at how they can do what we cant which is have success with in-house products and proven MOAs

those may be good adds but have not yet moved the needle on stock price and, therefore, shareholder value.

I just don’t see our actions and investor relations building confidence in the company’s future prospects. If an investor sees and hears a well articulated plan, they’ll put dollars there. If shareholders don’t get a return or understand the plan, they take their dollars elsewhere. We don’t grow value or inspire confidence that we can provide future returns.

There was an earlier point that resonates with me. What company has EVER booked billions and billions in unforecasted sales and have so little to show for it? Our stock price now is below the Jan 2020 levels.

 

[anonymous]

Yeah, I hope most people did. During the pandemic run up on covid vaccines sales, I pulled some off the table in the mid fifties. I didn’t hit the top like AB and the insiders, but I’m ok with what I pulled off my holdings.

what I am not ok with is how AB and the insiders have bungled this whole scenario. While they have become individually wealthy, they have completely lost the opportunity to redefine how PFE is perceived as a vaccine leader, an effective communicator that shapes narratives or as a trusted place for investors to get reasonable returns. We should do more than compete for CD investors, we could be a leader in healthcare stocks. Billions upon billions sold, opportunities squandered and drift back to below the pre pandemic mean. Just absolutely awful leadership. Maybe the next book can be called Rimshot.

You're clearly not employed by Pfizer. You're making perfect sense: that is the dead give-away!

 

[anonymous]

bought seagen and biohaven... not really blown when you look at how they can do what we cant which is have success with in-house products and proven MOAs

It will be blown when they don’t retain seagen’s experienced leadership and continue to run onc like pc.

 

[anonymous]

those may be good adds but have not yet moved the needle on stock price and, therefore, shareholder value.

I just don’t see our actions and investor relations building confidence in the company’s future prospects. If an investor sees and hears a well articulated plan, they’ll put dollars there. If shareholders don’t get a return or understand the plan, they take their dollars elsewhere. We don’t grow value or inspire confidence that we can provide future returns.

There was an earlier point that resonates with me. What company has EVER booked billions and billions in unforecasted sales and have so little to show for it? Our stock price now is below the Jan 2020 levels.

Biohaven acquisition has not yet helped. Seagen has not closed and hung up in FTC reviews. Given the political fawning by AB during pandemic and SS constant progressive slobbering, you would think we could smooth the process a little. Wall Street knows our limitations and prices PFE accordingly. Remember the old times when Pfizer defended keeping HQ in NYC because it gave us a financial advantage and connections with Wall Street? A joke then and still today.

Approval of Covid vaccine yesterday and down nearly 1%. I get that CDC guidance is still needed but the main issue remains that we did not and still have not built confidence among the broader population that the vaccine is understood in mechanism of action, is proven safe, and is effective for individual protection. We allowed the magical hype of mRNA to confuse people and thereby generate distrust. We did not correct politicians and political leaning healthcare spokespeople who blathered about “herd” or “protecting those around you”. Narrative lost and long term opportunities diminished. Great to get the billions then, hard to meet the forecasts now. That is failed leadership that does not look forward or understand the market they bought into.

 

[anonymous]

Don’t worry guys, Count Chocula is working on raising that stock price! I’m sure he’s meeting with BlackRock now and doubling down on all this ESG horseshit. We have a crappy pipeline, but look at all lesbians we hired! ‍

 

[anonymous]

It will be blown when they don’t retain seagen’s experienced leadership and continue to run onc like pc.

Unfortunately, you described our MO. Strong leadership from the companies that we buy refuse to work here. So what do we do? Promote the absolute wrong people from within, and try to apply tactics that once worked for Viagra and Lipitor decades ago. As my Dad used to say "it's like a broken record".

 

[anonymous]

Pick up your iPhone. Open the business news app. Enter PFE. Select 1 day and see a red line chart. Select 1 week, see a red line chart. Select 1 month, 3 months, 6 months, YTD, 1 year, 2 years, 5 years and see a RED line chart for each. You have to go out to 10 years to find anything green.

Now consider that just over three years ago, no one heard of SARS co-v 2. No one had billions of vaccine and treatment sales in our forecast. Yet our leadership has failed to translate this into an investor win. We have sown no need confidence with investors or the general public. We have only managed to pay exorbitant amounts to execs and come up with the same cost cut / buy assets “strategy” that we8ve followed for decades. Insane.

I saw this post a few weeks ago and thought that it was hyperbole. I have done done this day, week, month check nearly every day since. With only a few days exceptions, this has held true for nearly six weeks now. It really is remarkable that Pfizer could bungle this Covid windfall of sales with no enduring benefit to shareholders

 

[anonymous]

I saw this post a few weeks ago and thought that it was hyperbole. I have done done this day, week, month check nearly every day since. With only a few days exceptions, this has held true for nearly six weeks now. It really is remarkable that Pfizer could bungle this Covid windfall of sales with no enduring benefit to shareholders

Remarkable, but not unpredictable. We are Pfizer, and this is what we do.

 

[anonymous]

As an investment, I like the analogy of PFE being like a CD but with downside risk.

we are also analogous to a fool who wins the lottery. Blow through the money in two years, have nothing to show for it. No plan, just a hope for another bonanza from somewhere.

New week and the downward March continues.

 

[anonymous]

CFO today brought down all vaccine stocks with his comments at the JP Morgan conference. Also mentioned 2x PFE weight loss drug is twice a day. He didn’t say anything positive or uplifting about the product. Needs to guard his words better. I wouldn’t be surprised if the insiders already know PFE BID and side effects will prevent it from competing with Lilly and Novo. I guess we will have some additional information during Q3 earnings call at the end of October. Someone seems to know something that is driving the price down. PFE is way more than a vaccine company so the question is, what’s been leaked to the street? He also talked about across the board cost reductions if new products don’t meet expectations.